ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 176,31
0,46%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Adaptive Biotechnologies Corporation (ADPT)

  7. Adaptive Biotechnologies Corporation (ADPT) Actualités

ADPT Adaptive Biotechnologies Corporation

3,01
0,08 (2,73%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Adaptive Biotechnologies Corporation ADPT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,08 2,73% 3,01 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,99 2,95 3,14 3,01 2,93
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
17/4/202422:05GLOBEAdaptive Biotechnologies to Report First Quarter 2024..
02/4/202422:05GLOBEAdaptive Biotechnologies Provides Strategic Review Update..
27/3/202413:30GLOBEAdaptive Biotechnologies to Hold a Business Update..
07/3/202401:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202401:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202401:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202401:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202401:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202401:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202401:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202401:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202401:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202401:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202401:38EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/2/202422:05GLOBEAdaptive Biotechnologies to Present at the TD Cowen 44th..
14/2/202422:15EDGAR2Form 8-K - Current report
14/2/202422:05GLOBEAdaptive Biotechnologies Reports Fourth Quarter and Full..
29/1/202422:05GLOBEAdaptive Biotechnologies to Report Fourth Quarter and Full..
29/1/202422:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
27/12/202322:05GLOBEAdaptive Biotechnologies to Present at the 42nd Annual J.P...
09/12/202314:30GLOBEAdaptive Biotechnologies Announces New Data Highlighting the..
05/12/202313:30GLOBEAdaptive Biotechnologies and Collaborators to Present More..
20/11/202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202322:15EDGAR2Form 8-K - Current report
09/11/202322:05GLOBEAdaptive Biotechnologies Reports Third Quarter 2023..
07/11/202313:30GLOBEAdaptive Biotechnologies Announces New Translational..
02/11/202321:05GLOBEAdaptive Biotechnologies to Report Third Quarter Financial..
13/9/202313:30GLOBEAdaptive Announces Launch of Epic Integration for clonoSEQ®
01/9/202323:16EDGAR2Form 8-K - Current report
30/8/202322:30GLOBEAdaptive Biotechnologies to Participate in the Morgan..
08/8/202323:26EDGAR2Form 144 - Report of proposed sale of securities
08/8/202322:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202322:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202322:17EDGAR2Form 8-K - Current report
02/8/202322:05GLOBEAdaptive Biotechnologies Reports Second Quarter 2023..
10/7/202322:05GLOBEAdaptive Biotechnologies to Report Second Quarter Financial..
03/7/202321:14EDGAR2Form 8-K - Current report
02/6/202313:34GLOBEAdaptive Biotechnologies Highlights New Data at ASCO 2023..
24/5/202322:05GLOBEAdaptive Biotechnologies to Participate in Upcoming June..
12/5/202314:00GLOBEAdaptive Biotechnologies to Participate in the 2023 RBC..
09/5/202313:30GLOBEAdaptive Biotechnologies Announces FDA Acceptance of..

Dernières Valeurs Consultées

NASDAQ
ADPT
Adaptive Biotechnologies
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés